Eli Lilly said it is investing another $5.3 billion in a manufacturing plant in Lebanon, Indiana, to expand the supply of its highly popular weight loss drug Zepbound, diabetes treatment Mounjaro ...

Expect to see the pace accelerate at the Eli Lilly and Co. project on Lebanon’s north side as weather warms. The $9 million ...

Eli Lilly & Co. (LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026. CEO Dave Ricks told Bloomberg News on Monday that data on the drug, orforglipron, is ...

On an investment spree with billions of dollars’ worth of projects ongoing globally, Indianapolis-based Eli Lilly and Company ...

Signs of change are all over Boone County. Fences , flags and construction cones mark where two future Eli Lilly manufacturing facilities will one day make medicine. Signs of change are all over ...

Nearly 200 Eli Lilly and Co. employees from the Lebanon site under construction volunteered to distribute 75,000 diapers to ...

Lebanon's Eli Lilly and Co. employees recently donated to the Caring Center more than 530 pounds of food which according to ...

Eli Lilly and Co. CEO David Ricks—IBJ ... high of $972 and announcements about big new investments in Lebanon and Ireland. Lilly’s stock price has retreated since that high mark, but Lilly ...

In a report released today, Terence Flynn from Morgan Stanley reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), with a ...